Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Queensland Health
Colorcon
QuintilesIMS
Fish and Richardson
Citi
Covington
Farmers Insurance
Deloitte

Generated: May 23, 2018

DrugPatentWatch Database Preview

MEDIPREN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Medipren, and when can generic versions of Medipren launch?

Medipren is a drug marketed by Mcneil and is included in two NDAs.

The generic ingredient in MEDIPREN is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and sixty-six suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
Summary for MEDIPREN
US Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: 135
Formulation / Manufacturing:see details
DailyMed Link:MEDIPREN at DailyMed
Drug patent expirations by year for MEDIPREN
Medical Subject Heading (MeSH) Categories for MEDIPREN

US Patents and Regulatory Information for MEDIPREN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mcneil MEDIPREN ibuprofen TABLET;ORAL 070475-001 Feb 6, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mcneil MEDIPREN ibuprofen TABLET;ORAL 071215-001 Jun 26, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Baxter
Cipla
Chubb
Citi
AstraZeneca
Fuji
Harvard Business School
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.